4-bromo-6-hydroxy-5-methoxy-2-methyl-3H-isoindol-1-one | 1360546-57-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 4-bromo-6-hydroxy-5-methoxy-2-methyl-3H-isoindol-1-one
• CAS: 1360546-57-1
• 化学式: C₁₀H₁₀BrNO₃
• 分子量: 272.098
• InChiKey: YJIFDZATHIHAOQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-bromo-6-hydroxy-5-methoxy-2-methyl-3H-isoindol-1-one 、 2-甲酰基苯硼酸 在 四(三苯基膦)钯 、 caesium carbonate 作用下， 以 乙醇 、 甲苯 为溶剂， 反应 0.17h， 生成 2-羟基-1-甲氧基-5-甲基二苯并(cd,f)吲哚-4(5H)-酮
  参考文献：
  名称：

  Synthesis of aristolactam analogues and evaluation of their antitumor activity

  摘要：

  A series of natural aristolactams and their analogues have been prepared and evaluated for antitumor activity against human cancer cells, including multi-drug resistant cell lines. Naturally occurring aristolactams, such as aristolactam BII (cepharanone B), aristolactam BIII, aristolactam FI (piperolactam A), N-methyl piperolactam A, and sauristolactam showed moderate antitumor activities in selected cell lines. However, several synthetic aristolactam derivatives exhibited potent antitumor activities against a broad array of cancer cell lines with GI(50) values in the submicromolar range. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.04.020

文献信息

• Synthesis of aristolactam analogues and evaluation of their antitumor activity
  作者：Young Lok Choi、Joa Kyum Kim、Sang-Un Choi、Yong-Ki Min、Myung-Ae Bae、Bum Tae Kim、Jung-Nyoung Heo

  DOI：10.1016/j.bmcl.2009.04.020

  日期：2009.6

  A series of natural aristolactams and their analogues have been prepared and evaluated for antitumor activity against human cancer cells, including multi-drug resistant cell lines. Naturally occurring aristolactams, such as aristolactam BII (cepharanone B), aristolactam BIII, aristolactam FI (piperolactam A), N-methyl piperolactam A, and sauristolactam showed moderate antitumor activities in selected cell lines. However, several synthetic aristolactam derivatives exhibited potent antitumor activities against a broad array of cancer cell lines with GI(50) values in the submicromolar range. (C) 2009 Elsevier Ltd. All rights reserved.